[HTML][HTML] Breast cancer: miRNAs monitoring chemoresistance and systemic therapy
With a high mortality rate that accounts for millions of cancer-related deaths each year,
breast cancer is the second most common malignancy in women. Chemotherapy has …
breast cancer is the second most common malignancy in women. Chemotherapy has …
Cross-roads to drug resistance and metastasis in breast cancer: miRNAs regulatory function and biomarker capability
Breast cancer and specifically metastatic breast cancer (mBC) constitutes a major health
burden worldwide with the highest number of cancer-related mortality among women across …
burden worldwide with the highest number of cancer-related mortality among women across …
MicroRNAs in breast cancer: one More Turn in Regulation
PE Asensio, ET Martin, BP Merlo… - Current drug …, 2016 - ingentaconnect.com
MicroRNAs (miRNAs) are small non-coding RNA molecules that critically regulate the
expression of genes. MiRNAs are involved in physiological cellular processes; however …
expression of genes. MiRNAs are involved in physiological cellular processes; however …
MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications
W Tian, J Chen, H He, Y Deng - Clinical and Translational Oncology, 2013 - Springer
Breast cancer is the most common malignancy and leading cause of cancer mortality in
women. Drug resistance is a major obstacle in systemic therapy of breast cancer, which …
women. Drug resistance is a major obstacle in systemic therapy of breast cancer, which …
MicroRNAs in breast cancer therapy
J Tang, A Ahmad, FH Sarkar - Current pharmaceutical design, 2014 - ingentaconnect.com
Breast cancer is one of the most common type of cancers as well as a principal cause of
cancer-related deaths in women worldwide. Although research has provided a better …
cancer-related deaths in women worldwide. Although research has provided a better …
The role of microRNAs in the chemoresistance of breast cancer
J Wang, M Yang, Y Li, B Han - Drug development research, 2015 - Wiley Online Library
ABSTRACT Preclinical Research Breast cancer is the most prevalent malignancy in women
with more than 1.3 million new cases every year worldwide. Chemotherapy is a critical …
with more than 1.3 million new cases every year worldwide. Chemotherapy is a critical …
miRNAs in breast cancer: ready for real time?
Over the past decade, major advances in our comprehension of breast cancer biology have
led to improved diagnostic and prognostic techniques and the development of novel …
led to improved diagnostic and prognostic techniques and the development of novel …
Therapeutic delivery of tumor suppressor miRNAs for breast cancer treatment
Simple Summary The most frequent cancer in women is breast cancer (BC), which presents
a significant risk to their good health. Over the past few decades, several factors have …
a significant risk to their good health. Over the past few decades, several factors have …
Clinical theragnostic relationship between drug-resistance specific miRNA expressions, chemotherapeutic resistance, and sensitivity in breast cancer: a systematic …
R Jayaraj, MR Madhav, SG Nayagam, A Kar… - Cells, 2019 - mdpi.com
Awareness of breast cancer has been increasing due to early detection, but the advanced
disease has limited treatment options. There has been growing evidence on the role of …
disease has limited treatment options. There has been growing evidence on the role of …
Role of microRNA deregulation in breast cancer cell chemoresistance and stemness
TA Tekiner, H Basaga - Current medicinal chemistry, 2013 - ingentaconnect.com
Studies with breast cancer cells, showed that microRNAs (miRNAs) act as regulators of
signaling pathways playing a key role in tumor progression and being targeted in …
signaling pathways playing a key role in tumor progression and being targeted in …
相关搜索
- breast cancer systemic therapy
- breast cancer mirna expressions
- breast cancer drug resistance
- sensitivity in breast cancer
- chemoresistance of breast cancer
- cases in breast cancer
- metastasis in breast cancer
- breast cancer basic evidence
- micrornas in breast cancer
- breast cancer clinical applications
- breast cancer real time
- breast cancer meta analysis
- drug resistance mirna expressions
- drug resistance basic evidence
- drug resistance clinical applications
- drug resistance meta analysis